Empowering patients through expanded access to accurate and timely genetic diagnosis.
Advancing the future of neurogenetic medicine through the development of novel therapeutics.
Driving innovation in neurogenetics through observational studies and interventional trials of genetic therapies.
Transforming care by leveraging Penn infrastructure to rapidly and safely deliver newly licensed genetic therapies to patients.
Fostering genetic literacy and therapeutic knowledge to prepare patients and providers for the future of genetic medicine.
Congratulations to Laynie Dratch, SCM, LCGC on receiving the University of Pennsylvania MSGC Program’s 2026 Outstanding Clinical Supervisor Award!
A big congratulations to Genetic Counselor Rachel Paul on contributing to a newly published study in Oxford Academic’s Brain.
An exciting moment for Penn Medicine Against ALS today; we are incredibly proud to announce that we have been named a Discovery Award Winner in the #LongitudePrizeonALS!
PNTC is excited to announce that center director Dr. Jim Dowling, MD, PhD was the recipient of the Sidney Carter Award in Child Neurology at the 2026 American Academy of Neurology (AAN).
The neurogenetics team at Penn has reached a major milestone: 5,000 patients served!
Defne Amado, MD, PhD has received a Career Development Award from the American Society for Gene and Cell Therapy (ASGCT)!